DuPont Files 8-K on Material Agreement & Financial Obligation

TL;DR

DuPont just signed a big deal and took on a new financial obligation. Details in the 8-K.

AI Summary

On October 2, 2025, DuPont de Nemours, Inc. filed an 8-K report detailing a material definitive agreement and a direct financial obligation. The filing indicates the company entered into a significant contract and incurred a financial commitment, the specifics of which are detailed within the report.

Why It Matters

This filing signals a significant new contract or financial commitment for DuPont, which could impact its future operations and financial standing.

Risk Assessment

Risk Level: medium — Material definitive agreements and new financial obligations can introduce both opportunities and risks, depending on the terms and scale.

Key Players & Entities

• DuPont de Nemours, Inc. (company) — Registrant
• 0001193125-25-228420 (filing_id) — Accession Number
• October 2, 2025 (date) — Date of Report
• Delaware (jurisdiction) — State of Incorporation
• 001-38196 (commission_file_number) — SEC File Number

FAQ

Key Financial Figures

• $0.01 — ich registered Common Stock, par value $0.01 per share DD New York Stock Exchang
• $1,584,398,000 — fers, on October 2, 2025, DuPont issued $1,584,398,000 aggregate principal amount of 4.725% No
• $225,963,000 — Notes tendered and accepted by DuPont, $225,963,000 aggregate principal amount of 5.319% No
• $294,781,000 — tes tendered and accepted by DuPont and $294,781,000 aggregate principal amount of 5.419% No
• $900,000,000 — tion, a "Special Mandatory Redemption") $900,000,000 principal amount of the New 2028 Notes,

Filing Documents

• d32816d8k.htm (8-K) — 37KB
• d32816dex42.htm (EX-4.2) — 31KB
• d32816dex43.htm (EX-4.3) — 349KB
• d32816dex47.htm (EX-4.7) — 97KB
• 0001193125-25-228420.txt ( ) — 742KB
• dd-20251002.xsd (EX-101.SCH) — 3KB
• dd-20251002_lab.xml (EX-101.LAB) — 18KB
• dd-20251002_pre.xml (EX-101.PRE) — 11KB
• d32816d8k_htm.xml (XML) — 4KB

From the Filing

8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 2, 2025 DuPont de Nemours, Inc. (Exact name of registrant as specified in its charter) Delaware 001-38196 81-1224539 (State or other jurisdiction of incorporation) (Commission file number) (IRS Employer Identification No.) 974 Centre Road , Building 730 Wilmington , Delaware 19805 (Address of Principal Executive Offices) (Zip Code) (302) 295-5783 (Registrant's Telephone Number, Including Area Code) Not applicable (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, par value $0.01 per share DD New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). Emerging growth company If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. Item1.01 Entry into a Material Definitive Agreement Consent Solicitations – Third Supplemental Indenture DuPont de Nemours, Inc. ("DuPont") previously announced its offers to exchange (each an "Exchange Offer" and, collectively, the "Exchange Offers") its outstanding 4.725% Notes due 2028 (the "2028 Notes"), 5.319% Notes due 2038 (the "2038 Notes") and 5.419% Notes due 2048 (the "2048 Notes" and, collectively with the 2028 Notes and 2038 Notes, the "Existing Notes") for new notes to be issued by DuPont. As previously announced, concurrently with the Exchange Offers, DuPont also solicited consents from eligible holders of each series of Existing Notes (each, a "Consent Solicitation" and, collectively, the "Consent Solicitations") to adopt certain proposed amendments to the indenture governing each series of the Existing Notes (the "Proposed Amendments"). The Exchange Offers and Consent Solicitations were made upon the complete terms and subject to the conditions set forth in the confidential Offering Memorandum and Consent Solicitation Statement, dated September 2, 2025, as supplemented by the Supplement No. 1 to such Offering Memorandum and Consent Solicitation Statement, dated as of September 15, 2025, and as amended by the press release issued by DuPont on September 16, 2025 (together, the "Offering Memorandum and Consent Solicitation Statement"). The requisite number of consents were received as of 5:00 p.m., New York City time, on September 30, 2025 (the "Expiration Date") to adopt the Proposed Amendments with respect to the 2028 Notes and, accordingly, the following supplemental indenture to give effect to the Proposed Amendments with respect to the 2028 Notes became operative on October 2, 2025: Third Supplemental Indenture, dated as of September 15, 2025, by and between DuPont de Nemours, Inc. (f/k/a DowDuPont Inc.) and U.S. Bank Trust Company, National Association (including as successor in interest to U.S. Bank National Association), as trustee, relating to DuPont's outstanding 4.725% Notes due 2028. The above description of the material terms of the Third Supplemental Indenture does not purport to be complete and is qualified in its entirety by reference to the full text of the Third Supplemental Indenture attached hereto as Exhibit 4.2, the terms of which are in each case incorporated herein by reference. The requisite consents were not received to adopt the Proposed Amendments with respect to DuPont's 2038 Notes or 2048 Notes, and the Proposed Amendments will not be made with respect to such series of Existing Notes. Issuance of Senior Notes In connection with the settlement of the Exchange Offers, on October 2, 2025, DuPont issued $1,584,398,000 aggregate principal amount of 4.725% Notes due 2028 (the "New 2028 Notes") in exchange for the 2028 Notes tendered and accepted by DuPont, $225,963,000 aggregate principal amount of 5.319% Notes due 2038 (the "New 2038 Notes") in exchange for the 2038 Notes tendered and accepted by DuPont and $294,781,000

View Full Filing

View this 8-K filing on SEC EDGAR